Holdings of the Fund as of 2/11/2026
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,746.12 |
3.39% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$62,610.67 |
3.00% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$62,223.30 |
2.98% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$53,961.86 |
2.59% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$51,753.78 |
2.48% |
| Waters Corporation |
WAT |
941848103 |
148 |
$48,721.60 |
2.33% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,418.15 |
2.32% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$47,085.82 |
2.26% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$46,139.16 |
2.21% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$45,934.09 |
2.20% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$45,626.31 |
2.19% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$45,697.20 |
2.19% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$44,510.40 |
2.13% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,228.01 |
2.12% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$44,137.51 |
2.12% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$43,336.06 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,172.15 |
2.07% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,017.98 |
2.06% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$42,758.87 |
2.05% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,251.44 |
2.02% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$41,707.80 |
2.00% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$41,759.86 |
2.00% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,051.45 |
1.97% |
| Steris Plc |
STE |
G8473T100 |
169 |
$41,146.43 |
1.97% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$40,464.59 |
1.94% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$40,251.81 |
1.93% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$40,064.92 |
1.92% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$39,549.27 |
1.90% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,643.30 |
1.90% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$39,354.46 |
1.89% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$38,973.60 |
1.87% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$39,027.84 |
1.87% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$38,652.68 |
1.85% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$38,164.14 |
1.83% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,148.16 |
1.83% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$37,906.48 |
1.82% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$37,638.80 |
1.80% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$37,271.04 |
1.79% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$37,416.32 |
1.79% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$35,721.30 |
1.71% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$35,349.10 |
1.69% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$34,701.08 |
1.66% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$34,190.59 |
1.64% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$33,905.97 |
1.62% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$33,101.06 |
1.59% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,322.44 |
1.55% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$32,232.97 |
1.54% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$31,857.95 |
1.53% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$30,710.46 |
1.47% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$25,915.34 |
1.24% |
| US Dollar |
$USD |
|
2,107 |
$2,107.33 |
0.10% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|